
TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - Rapid Oral Sessions
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/j.1432-2277.2011.01350.x
DO  - doi:10.1111/j.1432-2277.2011.01350.x
SP  - 131
EP  - 229
PY  - 2011
ER  - 

TY  - JOUR
TI  - 55th Annual Teratology Society Meeting
JO  - Birth Defects Research Part A: Clinical and Molecular Teratology
JA  - Birth Defects Research Part A: Clinical and Molecular Teratology
VL  - 103
IS  - 5
SN  - 1542-0752
UR  - https://doi.org/10.1002/bdra.23387
DO  - doi:10.1002/bdra.23387
SP  - 311
EP  - 468
PY  - 2015
ER  - 

TY  - JOUR
AU  - Yan, Tristan D.
AU  - Zappa, Luis
AU  - Edwards, Gary
AU  - Alderman, Robert
AU  - Marquardt, Christina E.
AU  - Sugarbaker, Paul H.
TI  - Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database
JO  - Journal of Surgical Oncology
JA  - J. Surg. Oncol.
VL  - 96
IS  - 2
SN  - 0022-4790
UR  - https://doi.org/10.1002/jso.20736
DO  - doi:10.1002/jso.20736
SP  - 102
EP  - 112
KW  - morbidity and mortality
KW  - colorectal cancer
KW  - ovarian cancer
KW  - gastric cancer
KW  - cytoreduction
KW  - perioperative intraperitoneal chemotherapy
KW  - peritonectomy
PY  - 2007
AB  - Abstract Background Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy has expanded its application in the management of peritoneal carcinomatosis from gastrointestinal and ovarian malignancies. An accurate assessment of perioperative outcomes is crucial for integration of this combined procedure into clinical practice. Methods A prospective study of 80 patients undergoing the combined treatment for non-appendiceal peritoneal carcinomatosis was conducted. Forty-seven adverse events by eight organ-systems were rated from Grade I to IV with increasing severity. Results One patient (1.3%) died postoperatively. Postoperative adverse events affected genitourinary system (38%), hematological system (31%), gastrointestinal system (25%), infection (20%), intravenous catheters status (15%), pulmonary system (14%), cardiovascular system (11%) and neurological system (4%). Thirty-six patients (45%) experienced 49 Grade III adverse events. Six patients (8%) experienced eight Grade IV adverse events. More than four peritonectomy procedures (P?=?0.010), and length of hospital stay of more than 21 days (P?=?0.007) were strongly associated with Grade III and/or Grade IV morbidity. Conclusion The morbidity and mortality rates after the combined treatment for non-appendiceal peritoneal carcinomatosis were within the acceptable range of surgical treatments for other gastrointestinal cancers. A standardized prospective database is required for an accurate assessment of perioperative outcomes. J. Surg. Oncol. 2007;96:102?112. ? 2007 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - 6th Congress of the European College of Equine Internal Medicine
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 28
IS  - 2
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.12326
DO  - doi:10.1111/jvim.12326
SP  - 696
EP  - 710
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14917
DO  - doi:10.1111/ajt.14917
SP  - 245
EP  - 478
PY  - 2018
ER  - 

TY  - JOUR
TI  - Free Papers
JO  - Artificial Organs
VL  - 19
IS  - 10
SN  - 0160-564X
UR  - https://doi.org/10.1111/j.1525-1594.1995.tb02266.x
DO  - doi:10.1111/j.1525-1594.1995.tb02266.x
SP  - 1036
EP  - 1071
PY  - 1995
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00029.x
DO  - doi:10.1111/j.1538-7836.2007.tb00029.x
SP  - P-T-401
EP  - P-T-700
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Diseases of the Esophagus
JA  - Dis Esophagus
VL  - 27
IS  - S1
SN  - 1120-8694
UR  - https://doi.org/10.1111/dote.12287
DO  - doi:10.1111/dote.12287
SP  - 3A
EP  - 168A
PY  - 2014
ER  - 

TY  - JOUR
TI  - presented at the Annual General Meeting of the British Society for Haemostasis and Thrombosis, University of Nottingham, 19-20 March 1992
JO  - British Journal of Haematology
VL  - 80
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.1992.tb04551.x
DO  - doi:10.1111/j.1365-2141.1992.tb04551.x
SP  - 1
EP  - 35
PY  - 1992
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstractsâ€¨Cardiopulmonary
JO  - Artificial Organs
VL  - 27
IS  - 4
SN  - 0160-564X
UR  - https://doi.org/10.1046/j.1525-1594.2003.00011.x
DO  - doi:10.1046/j.1525-1594.2003.00011.x
SP  - 300
EP  - 347
PY  - 2003
ER  - 

TY  - JOUR
TI  - Posters
JO  - Diabetic Medicine
VL  - 22
IS  - s2
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2005.01668.x
DO  - doi:10.1111/j.1464-5491.2005.01668.x
SP  - 29
EP  - 121
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts-Poster Sessions
JO  - Transfusion Medicine
JA  - Transfusion Med
VL  - 27
IS  - S2
SN  - 0958-7578
UR  - https://doi.org/10.1111/tme.12471
DO  - doi:10.1111/tme.12471
SP  - 24
EP  - 70
PY  - 2017
ER  - 

TY  - JOUR
TI  - Oral Presentation
JO  - Journal of Diabetes Investigation
VL  - 3
IS  - s1
SN  - 2040-1116
UR  - https://doi.org/10.1111/jdi.12012
DO  - doi:10.1111/jdi.12012
SP  - 79
EP  - 146
PY  - 2012
ER  - 

TY  - JOUR
TI  - Posters
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 107
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2010.00600.x
DO  - doi:10.1111/j.1742-7843.2010.00600.x
SP  - 162
EP  - 692
PY  - 2010
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - Pediatric Dermatology
VL  - 9
IS  - 2
SN  - 0736-8046
UR  - https://doi.org/10.1111/j.1525-1470.1992.tb01235.x
DO  - doi:10.1111/j.1525-1470.1992.tb01235.x
SP  - 168
EP  - 230
PY  - 1992
ER  - 

TY  - JOUR
TI  - XIX International Congress of Neuropathology
JO  - Brain Pathology
JA  - Brain Pathol
VL  - 29
IS  - S1
SN  - 1015-6305
UR  - https://doi.org/10.1111/bpa.12675
DO  - doi:10.1111/bpa.12675
SP  - 3
EP  - 198
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral abstracts
JO  - American Journal of Transplantation
VL  - 10
IS  - s4
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2010.03107.x
DO  - doi:10.1111/j.1600-6143.2010.03107.x
SP  - 37
EP  - 212
PY  - 2010
ER  - 

TY  - JOUR
AU  - Lee IV, Major K.
AU  - Lewis, Russell S.
AU  - Strasberg, Steven M.
AU  - Hall, Bruce L.
AU  - Allendorf, John D.
AU  - Beane, Joal D.
AU  - Behrman, Stephen W.
AU  - Callery, Mark P.
AU  - Christein, John D.
AU  - Drebin, Jeffrey A.
AU  - Epelboym, Irene
AU  - He, Jin
AU  - Pitt, Henry A.
AU  - Winslow, Emily
AU  - Wolfgang, Christopher
AU  - Vollmer Jr, Charles M.
TI  - Defining the post-operative morbidity index for distal pancreatectomy
JO  - HPB
JA  - HPB
VL  - 16
IS  - 10
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12293
DO  - doi:10.1111/hpb.12293
SP  - 915
EP  - 923
PY  - 2014
AB  - Abstract Background Accurate assessment of complications is critical in analysing surgical outcomes. The post-operative morbidity index (PMI), derived from the Modified Accordion Severity Grading System and American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), is a quantitative measure of post-operative morbidity. This study utilizes PMI to establish the complication burden for a distal pancreatectomy (DP). Methods From 2005?2011, nine centres contributed ACS-NSQIP complication data for 655 DPs. Each complication was assigned an Accordion severity weight ranging from 0.11 for grade 1 to 1.00 for grade 6 (death). The PMI is the sum of complication severity weights divided by the total number of patients. Results ACS-NSQIP complications occurred in 177 patients (27.0%). The non risk-adjusted PMI for DP is 0.087. Bleeding/Transfusion and Organ Space Infection were the most common complications. Frequency and burden differed across Accordion grades. While grade 4?6 complications represented only 15.4% of complication occurrences, they accounted for 30.4% of the burden. Subgroup analysis demonstrates that the PMI did not vary based on laparoscopic versus open approach or the performance of a splenectomy. Discussion This study uses two validated systems to quantitatively establish the morbidity of a DP. The PMI allows estimation of both the frequency and severity of complications and thus provides a more comprehensive assessment of risk.
ER  - 
